In the news

Medtronic CEO Geoff Martha shares his perspective on the company’s dual commitment to patients and performance.

Established in 1997, the Visible Heart Laboratory helps Medtronic test lifesaving technology while training the next generation.

Kevin Hill is one of the earliest patients to benefit from adaptive deep brain stimulation. After years of sleepless nights and being unable to manage the uncontrollable shaking of his arm and leg, his tremors "stopped instantly.”

Medtronic CEO Geoff Martha joins Jim Cramer for a conversation about the company’s product pipeline, including new innovations in Parkinson’s treatment.

Molly Young’s doctors used Medtronic StealthStation™ navigation to map her brain, safely removing 95% of her tumor.

Dr. Khaldoun Tarakji, chief medical officer of cardiac ablation at Medtronic, shares how this new treatment option – called pulsed field ablation – can benefit patients.

In January, Veronica Brown became one of the first patients in the world to be implanted with a Percept RC deep brain stimulation device.

The InPen app is part of the larger Smart MDI System, which includes a continuous glucose monitor and smart insulin pen.

The company hopes to overcome longstanding health disparities and reach patients who may otherwise go untreated.

Medtronic CEO Geoff Martha joins ‘The Claman Countdown’ to discuss the company’s Q2 earnings results.

Dr. Rob Kowal, vice president of the cardiac pacing therapies business at Medtronic, shares the history behind the company’s first product.

Affera combines mapping technology with a catheter capable of performing both radiofrequency and pulsed field ablation.

Medtronic is so bullish on generative artificial intelligence, its executives say, that every department at the medical-device maker has been asked to come up with ways the technology can boost productivity or improve patient outcomes.

Braydon Wiedeman of Waite Park was in a serious car crash eight years ago. Thanks to a Medtronic spinal cord stimulator and hard work, he is now finding relief.

Medtronic employees are going back to school with the help of MAPS, a new company program that covers undergraduate tuition up-front at select academic institutions.

Medtronic CEO Geoff Martha sits down with KARE 11’s Julie Nelson to discuss the company’s 75th anniversary and forward trajectory.

Recent Medtronic approvals include treatments for chronic pain, high blood pressure, atrial fibrillation, and Parkinson’s.

Thanks to the Medtronic Percept RC, Bruce Lunde can now control his tremors remotely from his cell phone.

Medtronic hopes to tap the city’s abundance of doctors, hospitals, and universities to develop a technology that could revolutionize surgery with the help of robotics and artificial intelligence.

Bryan Larsen said schedule flexibility and encouragement from colleagues has allowed him to prepare for Paris.

Revenue grew nearly 12% in Medtronic’s diabetes business, the biggest increase among all of its business segments.

Medtronic CEO Geoff Martha joins ‘Money Movers’ to discuss the company’s Q1 earnings results.

Medtronic CEO Geoff Martha joins ‘The Claman Countdown’ to discuss the company’s Q1 earnings results.

Jessika Seward received a Medtronic pacemaker after a second-degree heart block, helping her return to normal life.

Medtronic is the first company to receive FDA approval for asleep DBS. Surgeons traditionally perform DBS procedures, a treatment for medical conditions like epilepsy and Parkinson’s disease, while the patient is awake.